Journal ArticleOPEN ACCESS

Is Long-acting Cabotegravir a Pre-exposure Prophylaxis Option for Women of Childbearing Potential?

Open Forum Infectious Diseases (2022) 9(7)
DOI: 10.1093/ofid/ofac230
5Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Long-acting cabotegravir (CAB-LA) provides an exciting new option for pre-exposure prophylaxis (PrEP) in multiple populations. In this Perspective, we consider the unique pharmacokinetics of CAB-LA and the potential impact on the prescribing of CAB-LA, specifically in cis-women of reproductive potential.

Author supplied keywords

Cite

CITATION STYLE

APA

Sahloff, E. G., Hamons, N., Baumgartner, K., & Duggan, J. M. (2022). Is Long-acting Cabotegravir a Pre-exposure Prophylaxis Option for Women of Childbearing Potential? Open Forum Infectious Diseases, 9(7). https://doi.org/10.1093/ofid/ofac230

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free